Enovis (ENOV) Treasury Shares (2011 - 2025)

Enovis (ENOV) posted quarterly Treasury Shares of $32000.0 for Q3 2021, down 96.7% quarter-over-quarter from $971000.0 in Q2 2021.

Enovis (ENOV) Treasury Shares (2011 - 2025) Analysis & Trends

Enovis (ENOV) has reported Treasury Shares for 4 consecutive years, with $32000.0 the latest figure, recorded in Q3 2021.

In Q3 2021, Treasury Shares changed N/A year-over-year to $32000.0; the TTM figure through Jul 2021 stood at $32000.0 (changed N/A YoY), while the FY2015 annual figure was $27.4 million, changed N/A from the prior year.
Treasury Shares declined to $32000.0 in Q3 2021 per ENOV's latest filing, from $971000.0 in the prior quarter.
Across five years, Treasury Shares topped out at $1.1 million in Q4 2025 and bottomed at $503279.0 in Q4 2022.
Historically, Treasury Shares has averaged $689662.8 across 5 years, with a median of $644255.0 in 2024.
On a YoY basis, Treasury Shares climbed as much as 99.75% in 2019 and fell as far as 99.75% in 2019.
Enovis' Treasury Shares stood at $56.1 million in 2018, then plunged by 99.35% to $366000.0 in 2019, then tumbled by 91.26% to $32000.0 in 2021.
Business Quant data shows ENOV's Treasury Shares at $32000.0 in Q3 2021, $971000.0 in Q2 2021, and $366000.0 in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Abbott Laboratories	199.44 Bn	193.84 Bn	7.27 Bn	267.91 Mn
2	Stryker	127.32 Bn	123.85 Bn	4.50 Bn	-
3	Medtronic	118.87 Bn	109.65 Bn	6.41 Bn	-
4	Boston Scientific	73.47 Bn	72.93 Bn	3.85 Bn	303.21 Mn
5	Edwards Lifesciences	51.90 Bn	47.65 Bn	1.35 Bn	85.10 Mn
6	Dexcom	34.30 Bn	32.36 Bn	830.00 Mn	2.73 Bn
7	GE HealthCare Technologies	33.74 Bn	31.63 Bn	2.18 Bn	525.00 Mn
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn	16.27 Mn
9	Steris	23.05 Bn	22.56 Bn	684.20 Mn	-
10	Enovis	1.51 Bn	1.49 Bn	359.25 Mn	-

Download Data